BCMA-Targeted Antibodies and T-Cells In: October 2016 R and D and Business Tracker for TCR and CAR T-Cells and NK Cells: Monthly Tracking Reports; New Report Launched
This pdf report contains information about TCR & CAR engineered T-cells and NK cells released during the month of October 2016. Featured presentations of October 2016 include the pipeline of B-Cell Maturation Antigen (BCMA)-targeted antibodies & T-cells, the profile of US biotech Poseida Therapeutics and the profile of anti-BCMA CARtyrin T-cell product candidate P-BCMA-101 from Poseida Therapeutics.
View full press release